Mirai RiskTech
Mirai RiskTech provides banks with an integrated asset-liability management platform for managing balance-sheet risk and financial planning.
≤€5MVenture debt with minority equity kicker
LeadI
Inveready
Activity from announced rounds
Activity in this selectionOct 16, 2026 · Jul 19, 2026
- Rounds participated in
- 2
- Confirmed lead rounds
- 1 All roles disclosed
- New companies
- 2 First participation on record · 0 follow-on
- Funding in participating rounds
- $3.6M 1 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
2 in this selectionConnecta Therapeutics
Connecta Therapeutics develops small-molecule treatments for neurological disorders, including CTH120, a clinical-stage candidate for Fragile X syndrome.
€3.1MClinical development financing
Participant